Eurand to Present Zentase Phase III Data
MILAN, Italy, and DAYTON, Ohio, June 08, 2007
/PRNewswire-FirstCall/ --Eurand to present data on Zentase
European Cystic Fibrosis Society Annual
-- Exocrine pancreatic insufficiency (EPI) is a
deficiency of digestive
Eurand's Zentase Effective in Treating Exocrine Pancreatic
Insufficiency, Studies Show Zentase
Improves Absorption of Fat, Protein and Other Nutrients in
Patients with Mild, Moderate or Severe Malabsorption, While
Controlling Symptoms of Exocrine Pancreatic Insufficiency
MILAN, Italy and DAYTON, Ohio, June 19, 2007
/PRNewswire-FirstCall/ -- Eurand N.V. today announced results that
Eurand Announces Positive Phase III Clinical Study Results
...Administration (FDA) granted fast track status for zentase
treatment of EPI. The company intends to f...-in-class pancreatic enzyme replacement therapy.
is a zero-overfill, highly-stable, porcine-derived...variability in dosing. As a highly-stable
does not require overfill. Currently, there are no...
Zentase New Drug ApplicationZentase
information from Drugs.com, includes Zentase
side effects, interactions, indications ... Letter From FDA for EUR-1008 (Zentase
) - June 19, 2008 ...
Zentase NDA Granted Priority Review
The FDA is giving Zentase
, a pancreatic enzyme replacement therapy, priority review with a ... which makes Zentase
(pancrelipase capsules), completed ...
Eurand Provides Update On EUR-1008 (ZENTASE) (Nasdaq:EURX)
Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products ...
Eurand N.V - Eurand Provides Update On EUR-1008 (ZENTASE)
PHILADELPHIA, Sep 30, 2008 (GlobeNewswire ... stage development product EUR-1008 (ZENTASE
(r)), an innovative pancreatic enzyme ... About EUR-1008 (ZENTASE
Eurand Receives Approvable Letter From FDA for EUR-1008 (Zentase ...
Eurand Receives Approvable Letter From FDA for EUR-1008 (Zentase
) 6/19/2008 ... About EUR-1008 (Zentase
(tm) ... for EUR-1008 (Zentase
), intended for the ...
Eurand (Milan, Italy) Announces EUR-1008 (Zentase) Eligibility for ...
... (EURX) Announces EUR-1008 (Zentase
) Eligibility for European Centralized Review ... application for EUR-1008 (Zentase
) is eligible for Community (Centralized) ...